Clinical Trial Update: The Angioshield Study Feasibility II [NA]

View source ↗

Summary

The Angioshield Study Feasibility II trial by Neograft Technologies has completed its feasibility update for Coronary Artery Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Angioshield

Snippet

Sponsor: Neograft Technologies, Incorporated | Conditions: Coronary Artery Disease | NA | Status: COMPLETED